United States - English - NLM (National Library of Medicine)

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur. check for leaks by squeezing container firmly. if leaks are found, discard unit as sterility may be impaired. if supplemental medication is desired, follow directions below before preparing for administration. to add medication (use aseptic technique) preparation for administration (use aseptic technique) note: see appropriate i.v. administration set instructions for use. warning: do not use flexible container in series connections.

United States - English - NLM (National Library of Medicine)

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

United States - English - NLM (National Library of Medicine)

icu medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur. check for leaks by squeezing container firmly. if leaks are found, discard unit as sterility may be impaired. if supplemental medication is desired, follow directions below before preparing for administration. to add medication (use aseptic technique) preparation for administration (use aseptic technique) note: see appropriate i.v. administration set instructions for use. warning: do not use flexible container in series connections.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - dextrose,lidocaine hydrochloride - solution - 5,0.4 %

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - dextrose,lidocaine hydrochloride - solution - 5,0.4 %,

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (chloride ion - unii:q32zn48698, magnesium cation - unii:t6v3lhy838), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295 - dextrose monohydrate 5 g in 100 ml - 5% dextrose and electrolyte no. 48 injection (multiple electrolytes and dextrose injection, type 1, usp) is indicated as a source of water, electrolytes, and calories or as an alkalinizing agent. 5% dextrose and electrolyte no. 48 injection (multiple electrolytes and dextrose injection, type 1, usp) is contraindicated in patients

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - lactated ringer’s and 5% dextrose injection, usp is indicated as a source of water, electrolytes and calories or as an alkalinizing agent. lactated ringer’s and 5% dextrose injection, usp is contraindicated in: patients with a known hypersensitivity to sodium lactate (see warnings ).

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - lidocaine hydrochloride anhydrous 0.8 g in 100 ml - lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1) ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. lidocaine should not be used in patients with stokes-adams syndrome, wolff-parkinson-white syndrome, or with severe degrees of sinoatrial, atrioventricular, or intraventricular block. solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

United States - English - NLM (National Library of Medicine)

citra labs llc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - dextrose monohydrate 0.245 g in 10 ml - anticoagulant citrate dextrose solution, solution a, u.s.p. (acd-a), is intended for use as an anticoagulant in the extracorporeal blood processing with autologous prp systems in production of platelet rich plasma (prp). refer to the manufacturer's operator's manual of the autologous prp system for the directions for use. not for direct intravenous infusion

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 250 mg in 1 ml - 25% dextrose injection is indicated in the treatment of acute symptomatic episodes of hypoglycemia in the neonate or older infant to restore depressed blood glucose levels and control symptoms. other drugs, such as epinephrine and glucagon, should be considered in patients unresponsive or intolerant to dextrose (glucose). oral feeding of dextrose may be necessary in infants with frequently recurring hypoglycemic episodes or to prevent recurrences due to hyperinsulinemia. 25% dextrose injection also provides a minimal source of carbohydrate calories. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present.